BCL2 and Hyperglycemia: Collectively, our findings provide evidence that FOXD1 is a new transcriptional regulator of BCL-2 under hyperglycaemic conditions and that an unrecognized TRIM21-FOXD1-BCL-2 axis transduces signalling related to hyperglycaemia-induced cell apoptosis and tissue injury.